-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RNS-60 in Acute Ischemic Stroke
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RNS-60 in Acute Ischemic Stroke report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RNS-60 in Acute Ischemic Stroke Drug Details: RNS-60 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RNS-60 in Amyotrophic Lateral Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RNS-60 in Amyotrophic Lateral Sclerosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RNS-60 in Amyotrophic Lateral Sclerosis Drug Details: RNS-60 is under development...
-
Product Insights
NewAcute Ischemic Stroke – Drugs In Development, 2024
Empower your strategies with our Acute Ischemic Stroke – Drugs In Development, 2024 report and make more profitable business decisions. An acute ischemic stroke occurs when a clot blocks a brain blood vessel, depriving it of oxygen. Symptoms, like numbness, confusion, or difficulty speaking, arise suddenly. Immediate medical attention is crucial. Treatment focuses on restoring blood flow, often with clot-dissolving drugs or a thrombectomy. Recovery varies; rehabilitation helps regain lost abilities. Lifestyle changes and medication may prevent future strokes. Early recognition...
-
Product Insights
NewAllergic Asthma – Drugs In Development, 2024
Empower your strategies with our Allergic Asthma – Drugs In Development, 2024 report and make more profitable business decisions. Allergic asthma is a type of asthma triggered by exposure to allergens, substances that induce an allergic reaction in susceptible individuals. When someone with allergic asthma encounters these triggers, their immune system responds by inflaming and constricting the airways, leading to symptoms of asthma. Common allergens that can trigger asthma include pollen, dust mites, pet dander, mold, cockroach droppings, and certain foods....
-
Product Insights
NewRelapsing Remitting Multiple Sclerosis (RRMS) – Drugs In Development, 2024
Empower your strategies with our Relapsing Remitting Multiple Sclerosis (RRMS) – Drugs In Development, 2024 report and make more profitable business decisions. Relapsing-remitting multiple sclerosis (RRMS) is the most common form of multiple sclerosis (MS), a chronic autoimmune condition that affects the central nervous system. In RRMS, individuals experience intermittent episodes of new or worsening symptoms (relapses or exacerbations) lasting days to weeks, followed by periods of partial or complete recovery (remission) with stable or improved function. Symptoms of RRMS can...
-
Product Insights
NewTraumatic Brain Injury – Drugs In Development, 2024
Empower your strategies with our Traumatic Brain Injury – Drugs In Development, 2024 report and make more profitable business decisions. Traumatic brain injury (TBI) happens when an external mechanical force causes brain damage. Traumatic brain injury usually results from a violent blow or jolt to the head. Symptoms include headache, dizziness, nausea or vomiting, mood changes, fatigue or drowsiness, difficulty sleeping, and memory or concentration problems. Risk factors include age. Certain types of traumatic brain injury increase the risk of developing...
-
Product Insights
NewIschemic Stroke – Drugs In Development, 2024
Empower your strategies with our Ischemic Stroke – Drugs In Development, 2024 report and make more profitable business decisions. Ischemic stroke occurs when there is a disruption of blood flow to a part of the brain, leading to a lack of oxygen and nutrients. This can happen when a blood vessel that supplies blood to the brain becomes blocked or narrowed, often due to the formation of a blood clot or plaque buildup within the vessel. The blockage can occur within...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Timolol in Ocular Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Timolol in Ocular Hypertension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Timolol in Ocular Hypertension Drug Details:Timolol is under development for the treatment of...
-
Product Insights
Multiple Sclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Multiple Sclerosis Pipeline Drugs Development Market Report Overview Multiple sclerosis (MS) is a potentially debilitating disease in which the body's immune system eats away at the protective sheath (myelin) that covers nerves. Damage to myelin causes interference in the communication between the brain, spinal cord, and other areas of the body. Symptoms include numbness or weakness in one or more limbs, double vision or blurring of vision, tingling or pain in parts of the body, fatigue, and slurred speech. The...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – RNS-60
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry RNS-60 Drug Details RNS-60 is under development for the treatment of acute ischemic stroke,...